(Q54296983)

27 May 2018

title

Specific CD8⁺ T cells recognize human herpesvirus 6B. (English)

1 reference

27 May 2018

1 reference

27 May 2018

author name string

Larissa K Martin

series ordinal

1 reference

27 May 2018

Andrea Schub

series ordinal

1 reference

27 May 2018

Stefan Dillinger

series ordinal

1 reference

27 May 2018

language of work or name

English

0 references

publication date

26 September 2012

1 reference

27 May 2018

European Journal of Immunology

published in

1 reference

27 May 2018

volume

1 reference

27 May 2018

issue

1 reference

27 May 2018

page(s)

2901-2912

1 reference

27 May 2018

Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

A population-based study of primary human herpesvirus 6 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Update on human herpesvirus 6 biology, clinical features, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Impact of human herpesvirus-6 after haematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Association of human herpesvirus-6B with mesial temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Cellular immunotherapy for viral infection after HSC transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Human CD4+ T cell response to human herpesvirus 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

HHV-6 and the immune system: mechanisms of immunomodulation and viral escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Selective suppression of IL-12 production by human herpesvirus 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Conditional immortalization of human B cells by CD40 ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

T-Cell Immune Response to Human Herpesvirus-6 in Healthy Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Human herpesvirus-6A and -6B encode viral immunoevasins that downregulate class I MHC molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Downregulation of the T-cell receptor complex and impairment of T-cell activation by human herpesvirus 6 u24 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

CMV-specific TCR-transgenic T cells for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

SYFPEITHI: database for MHC ligands and peptide motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Identification of major histocompatibility complex class II-restricted antigens and epitopes of the Epstein-Barr virus by a novel bacterial expression cloning approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

Identification of human herpesvirus-6 as a causal agent for exanthem subitum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

7 January 2021

Activated B cells mediate efficient expansion of rare antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

7 January 2021

Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

7 January 2021

Establishment and functional characterization of human herpesvirus 6-specific CD4+ human T-cell clones

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

7 January 2021

Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

7 January 2021

Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

7 January 2021

An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242439

7 January 2021

Identifiers

DOI

10.1002/EJI.201242439

1 reference

27 May 2018

1 reference

27 May 2018